The company aims to develop and distribute procedures, products and software for cell-type-based microbiota analysis. The company may establish branches and subsidiaries in Switzerland and/or abroad and participate in other companies in Switzerland and/or abroad, acquire, hold, encumber and sell real estate and intellectual property rights in Switzerland and/or abroad, and conduct all commercial, financial or other business that is directly or indirectly related to the company's purpose. Furthermore, the company may grant loans or other financing to its direct or indirect shareholders and their direct or indirect subsidiaries, as well as to third parties, against payment or free of charge, and provide security of any kind for the liabilities of such persons or group companies, including guarantees, pledges and fiduciary transfers of the company's assets.